Study highlights collaborative team approach as key to St. George's heart health success

New study shows Obicetrapib significantly lowers LDL and Lp(a), offering hope to heart patients struggling to meet cholesterol targets despite current treatments.

This link will take you to a page that’s not on LinkedIn

Italy Peptide Anticoagulant Drugs Market Industry is expected to grow from 10.76(USD Million) in 2024 to 30 (USD Million) by 2035. The Italy Peptide Anticoagulant Drugs Market CAGR (growth rate) is ex...

CVDLINK will harness the power of data to deliver high impact, open access health insights, AI-powered tools, and federated storage systems. Check out the video for an introduction to the project, including our objectives and workflow. -- Funded by the European Union. Views and opinions expressed a

New research reveals that Ozempic and Wegovy, widely known for aiding weight loss, also offer significant cardiovascular benefits, marking a breakthrough in diabetes and heart disease management.

The effects of COVID-19 extend beyond the initial infection. Emerging research shows that even months or years after recovery, the virus may increase the risk of heart-related problems. From mild discomfort to serious cardiovascular events, the impact can be significant. Here's everything you need to know about this connection and how to protect your heart. You May Also Like: Prague and Beyond: 6 Amazing Places to Visit in Czechia…

Deep Vein Thrombosis Treatment Market Size to reach USD 2.03 Billion at 7.50% CAGR by 2034, Global Deep Vein Thrombosis Treatment Industry Analysis by drug, treatment, mode of administration, distribu...

Cardiovascular Needle Market growth is projected to reach USD 0.16 Billion, at a 6.30% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2024 to...

Myant Corp., a trailblazer in chronic disease prevention through precision medicine, has announced its acquisition of mmHg Inc.